TLR activation can up-regulate the expression of co-stimulatory molecules and B7 family members through the Myeloid differentiation primary response gene 88 (MyD88)/TNF receptor associated factor (TRAF)-6, resulting in tumor evasion from the immune response [64]. Here, TRAF6 is linked to neoplasm.